Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Otitis Externa : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Otitis Media




Patient Education
Ear, Nose, and Throat Center

Swimmer's Ear Overview

Swimmer's Ear Causes

Swimmer's Ear Symptoms

Swimmer's Ear Treatment




Author: Ariel A Waitzman, MD, FRCS(C), Assistant Professor of Otolaryngology, Wayne State University

Ariel A Waitzman is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, Canadian Society of Otolaryngology-Head & Neck Surgery, Michigan State Medical Society, and Ontario Medical Association

Editors: Orval Brown, MD, Director of Otolaryngology Clinic, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc; John E McClay, MD, Assistant Professor, Department of Otolaryngology, Division of Pediatric Otolaryngology, Children's Medical Center, University of Texas Southwestern Medical School; Paul D Petry, DO, FACOP, FAAP, Consulting Staff, Freeman Pediatric Care, Freeman Health System; Maureen Strafford, MD, Arnold P Gold Foundation Associate Professor, Departments of Anesthesiology and Pediatrics, Tufts University and Tufts-New England Medical Center

Author and Editor Disclosure

Synonyms and related keywords: otitis externa, OE, necrotizing otitis externa, NOE, malignant otitis externa, swimmer's ear, cellulitis, Pseudomonas aeruginosa, Staphylococcus aureus, Candida, Aspergillus, otalgia, lymphadenitis, hearing loss, tinnitus

Background

Otitis externa (OE) is a common disease affecting all age groups.1 OE usually represents an acute bacterial infection of the skin of the ear canal but can be caused by a fungal infection. Although OE rarely causes prolonged problems or serious complications, the infection is responsible for significant pain and acute morbidity.

Pathophysiology

OE is a superficial infection of the skin in the ear canal. Two common initiating events may lead to OE. If trapped in the ear canal, moisture may cause maceration of the skin and provide a good breeding ground for bacteria. This may occur after swimming (especially in contaminated water) or bathing, hence the common lay-term swimmer's ear. It may also occur in hot humid weather (when OE is more prevalent).

The second significant factor is trauma to the ear canal that allows invasion of bacteria into the damaged skin. This often occurs after attempts at cleaning the ear with a cotton swab, paper clip, or any other utensil that can fit into the ear.

Once infection is established, an inflammatory response occurs with skin edema. Exudate and pus often appear in the ear canal as well. If severe, the infection may spread and cause a cellulitis of the face or neck. The most common pathogen is Pseudomonas aeruginosa, followed by Staphylococcus aureus, then other gram-negative organisms. Occasionally, fungi, such as Candida or Aspergillus species, cause OE.

Necrotizing (or malignant) OE is a complication that occurs in patients who are immunocompromised or in those who have received radiotherapy to the skull base. In this condition, bacteria invade the deep soft tissues and cause osteomyelitis of the temporal bone. This is a life-threatening disorder with an overall mortality rate that approached 50% historically.

Frequency

United States

OE is a very common disease that occurs in all regions of the United States. The infection is believed to be more prevalent in hot and humid conditions.

International

Although OE is a very common disease that occurs worldwide, the infection is believed to be more prevalent in hot and humid conditions.

Mortality/Morbidity

  • OE can cause severe otalgia requiring narcotic pain relievers in some patients.
  • Temporary hearing loss is common secondary to canal occlusion.
  • Severe infections may cause lymphadenitis or cellulitis of the face or neck.
  • Necrotizing OE is a serious condition that requires prolonged treatment and often results in severe morbidity or mortality.

Race

No racial disposition is known.

Sex

OE affects both sexes equally.

Age

Although the infection can affect all age groups, OE appears to be most prevalent in the older pediatric and young adult population.



History

Patients with otitis externa (OE) may complain of the following:

  • Otalgia ranging from mild to severe
  • Hearing loss
  • Ear fullness or pressure
  • Tinnitus
  • Fever (occasionally)
  • Ear discharge
  • Itch (especially in fungal infections or chronic OE)
  • Severe deep pain (If experienced by a patient who is immunocompromised or diabetic, be alerted to the possibility of necrotizing OE.)

Physical

Characteristics of OE present upon physical examination may include the following:

  • Pain upon palpation of the tragus (anterior to ear canal) or when applying traction to the pinna (hallmark of OE)
  • Edema and redness of the ear canal (see Media file 1)
  • Purulent or serous discharge in the ear canal
  • Conductive hearing loss
  • Cellulitis of the face or neck or lymphadenopathy of the unilateral neck (in some patients)
  • Fungal OE characteristics include the following:
    • Fungal infections result in severe itch but less pain than bacterial OE.
    • A thick discharge that may be white or gray is often present.
    • Upon close examination, the discharge may have visible fungal elements or a fuzzy appearance.
  • Necrotizing (malignant) OE characteristics include the following:
    • The sine qua non of necrotizing OE is pain out of proportion to clinical findings.
    • Upon close examination, granulation tissue may be present in the ear canal.

Causes

Risk factors for OE include swimming (hence, the commonly used term swimmer's ear), any source of water trapped in the ear canal, trauma to the ear canal, and a hot humid environment.

  • Causative organisms for OE: These are usually Pseudomonas species, S aureus, or other gram-negative organisms.
  • Fungal OE
    • Fungal OE may result from overtreatment of the ear canal with topical antibiotics, or it occasionally may present de novo from moisture trapped in the ear canal.
    • The most common organisms involved with fungal OE are Candida and Aspergillus species; however, many others have been isolated.
  • Chronic OE
    • Chronic OE is a fairly common condition that may be the result of incomplete treatment of acute OE.2
    • However, chronic OE more often is caused by overmanipulation of the ear canal due to cleaning and scratching.
    • This results in a low-grade inflammatory response that further causes itching of the skin.
    • Eventually the skin thickens, and canal stenosis may occur.
  • Necrotizing OE: Necrotizing OE occurs in patients who are immunocompromised and represents a true osteomyelitis of the temporal bone.



Otitis Media

Other Problems to be Considered

Ear canal trauma
Temporomandibular Joint Syndrome
Ear canal foreign body
Ear canal carcinoma
Otitis media with a perforation or ventilation tube present



Lab Studies

  • Most persons with otitis externa (OE) are treated empirically.
  • A culture taken from the ear canal discharge may be helpful in individuals with OE that is not responding to the usual measures.

Imaging Studies

  • Imaging studies are only performed in persons with suspected necrotizing OE (ie, malignant).
  • Classically, radionucleotide bone scan and gallium scan have been used to make the diagnosis.
  • Currently, high-resolution CT scanning of the temporal bone plays a more important role.
  • Although MRI has not been used to the same extent as these other tests, MRI may also be useful.

Procedures

  • Use of an ear wick helps topical medication penetrate a severely swollen ear canal.
  • The wick may be commercially prepared from a hard sponge material that expands when wet (eg, Merocel ear wick, Pope Oto-Wick), cut from a bigger sponge by the physician, or made from a narrow packing gauze.
  • The wick is placed in the ear canal (unfortunately, this causes brief but significant discomfort) and is moistened with topical antibiotic eardrops.
  • The ear wick usually is removed after 2-3 days.



Medical Care

  • Topical treatment
    • Most cases of acute otitis externa (OE) respond well to topical treatment.
    • Antibiotic eardrops, with or without a steroid, are the mainstay of treatment.
    • Topical acidifying and drying agents may be used in mild or resolving cases and are useful in fungal infections.
    • Some patients require strong analgesics for the first few days of treatment.
  • Oral antibiotics
    • Most persons with OE do not require oral medications.
    • Administer oral antibiotics in individuals with cellulitis of the face or neck skin or in persons in whom severe edema of the ear canal limits penetration of topical agents.
    • Consider oral antibiotics in patients who are immunocompromised.
  • Intravenous antibiotics
    • Intravenous (IV) antibiotics are used in individuals with necrotizing OE.
    • They may also be appropriate in patients with severe cellulitis or in persons whose symptoms do not respond to topical and oral antibiotics.
    • A prolonged course of IV antibiotics lasting as many as 6 weeks may be needed for individuals with necrotizing OE.
    • If the patient is stable, IV antibiotics may be administered at home.
    • Begin treatment with antibiotics to cover pseudomonads and alter medication depending on culture results.

Surgical Care

  • Debridement
    • Surgical debridement is occasionally required in individuals with necrotizing (ie, malignant) OE.
    • Debridement of the ear canal is often necessary in more severe cases of OE or when a significant amount of discharge is present in the ear.
    • An otolaryngologist usually performs debridement using magnification and suction equipment.
    • Debridement is the mainstay of treatment for fungal infections.
  • Incision and drainage
    • Occasionally, an abscess forms in the ear canal. This usually occurs in OE caused by S aureus.
    • The abscess often requires a simple incision and drainage procedure that is usually performed by an otolaryngologist using a needle or small blade.

Consultations

  • Consider consultation with an otolaryngologist for persons with severe OE or when the patient does not respond to treatment as expected. Debridement of the ear canal is often necessary for resolution of the infection (see Surgical Care).
  • Necrotizing OE necessitates consultation with otolaryngology, infectious disease, and, in some instances, neurosurgery.

Activity

  • During treatment of OE and for 1-2 weeks following its resolution, advise the patient to keep the ear canal dry.
  • During bathing or showering, advise the patient to place an earplug or cotton ball lightly coated with petroleum jelly in the ear canal to prevent water penetration.



Drug Category: Otic antibiotic agents

Most individuals with otitis externa (OE) may be treated with topical antibiotic preparations. Some preparations also contain a corticosteroid ingredient to decrease inflammation.

Drug NameNeomycin, polymyxin B, hydrocortisone (Cortisporin Otic)
DescriptionAntibacterial and anti-inflammatory solution for otic use. Treats superficial bacterial infections of external auditory canal.
Adult Dose4-5 gtt instilled to affected ear qid
Pediatric Dose4 gtt instilled to affected ear qid
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsExtended use can lead to resistant infections and thinning or atrophy of skin; use with caution in patients with perforated TMs because of possible ototoxicity; as many as one third of patients may develop allergic hypersensitivity to neomycin component with redness and inflammation that may mimic persisting infection; a few patients have more severe local reaction

Drug NameOfloxacin (Floxin otic)
DescriptionPyridine carboxylic acid derivative with broad-spectrum bactericidal effect.
Adult Dose5-10 gtt instilled to affected ear bid
Pediatric Dose5 gtt instilled to affected ear bid
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsSuperinfections (usually fungal) may occur with prolonged or repeated antibiotic use

Drug NameCiprofloxacin (Ciloxan, Cipro HC Otic)
DescriptionFluoroquinolone with activity against pseudomonads, streptococci, MRSA, Staphylococcus epidermidis, and most gram-negative organisms but with no activity against anaerobes. Inhibits bacterial DNA synthesis and, consequently, growth.
Adult Dose3-5 gtt instilled to affected ear bid
Pediatric Dose3 gtt instilled to affected ear bid
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsSuperinfections (usually fungal) may occur with prolonged or repeated antibiotic use

Drug NameTobramycin and dexamethasone (TobraDex)
DescriptionTobramycin interferes with bacterial protein synthesis by binding to 30S and 50S ribosomal subunits, which results in defective bacterial cell membrane. Dexamethasone decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reducing capillary permeability.
Adult Dose5 gtt instilled to affected ear bid
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity
InteractionsEffects decreased when used concurrently with gentamicin
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsProbably should not use when eardrum perforation or ventilation tube is present because of possible ototoxicity

Drug NameGentamicin (Garamycin)
DescriptionAminoglycoside antibiotic used for gram-negative bacterial coverage.
Adult Dose5 gtt instilled to affected ear tid/qid
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsProbably should not use when eardrum perforation or ventilation tube is present because of possible ototoxicity; do not use to treat ocular infections that may become systemic; prolonged or repeated antibiotic therapy may result in bacterial or fungal overgrowth of nonsusceptible organisms and may lead to secondary infections

Drug NameCiprofloxacin and dexamethasone otic (Ciprodex)
DescriptionFluoroquinolone that inhibits bacterial DNA synthesis and, consequently, growth by inhibiting DNA gyrase and topoisomerases, which are required for replication, transcription, and translation of genetic material. Quinolones have broad activity against gram-positive and gram-negative aerobic organisms. Has no activity against anaerobes.
Dexamethasone decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reducing capillary permeability.
Adult Dose4 gtt bid instilled in affected ear or ears for 7 d
Pediatric Dose<6 months: Not established
>6 months: Administer as in adults
ContraindicationsDocumented hypersensitivity; viral infections that affect external ear canal
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsFor otic use only; warm bottle in hand and shake well before administration; avoid contaminating applicator tip; prolonged use may cause bacterial or fungal overgrowth; rare adverse effects include ear discomfort, ear pain, ear residue, and ear pruritus

Drug Category: Otic acidifying agents

These agents are useful in fungal OE or in mild infections believed to be bacterial. They can also be useful for prevention.

Drug NameAcetic acid in aluminium acetate (Domeboro)
DescriptionAluminium acetate has drying effect. Acetic acid works well in superficial bacterial infections of OE.
Adult Dose5 gtt instilled to affected ear bid/qid
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyA - Fetal risk not revealed in controlled studies in humans
PrecautionsAvoid use when eardrum perforation or ventilation tube is present; for external use only

Drug NameHydrocortisone and acetic acid otic solution (VoSoL, VoSoL HC)
DescriptionAcetic acid is antibacterial and antifungal; hydrocortisone is anti-inflammatory, antiallergic, and antipruritic. Works well in superficial bacterial infections of OE.
Adult Dose5 gtt bid/qid in canal or on ear wick
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsAvoid use when eardrum perforation or ventilation tube is present; for external use only; systemic acidosis may result from absorption

Drug NameAlcohol vinegar otic mix
DescriptionHomemade mix of 50% rubbing alcohol, 25% white vinegar, and 25% distilled water is as effective as pharmaceutical acidifying agents and less expensive. Very useful for prevention and can be used as flushing solution for fungal infections.
Adult Dose4-6 gtt instilled in affected ear bid/qid
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyA - Fetal risk not revealed in controlled studies in humans
PrecautionsAvoid use when eardrum perforation or ventilation tube is present

Drug Category: Oral antibiotics

These agents are used to treat severe infection or cellulitis. Fluoroquinolones are drugs of choice because of Pseudomonas species coverage.

Drug NameCiprofloxacin (Cipro)
DescriptionFluoroquinolone with activity against pseudomonads, streptococci, MRSA, S epidermidis, and most gram-negative organisms but with no activity against anaerobes. Inhibits bacterial DNA synthesis and, consequently, growth.
Adult Dose250-500 mg PO bid
Pediatric Dose<18 years: Not recommended
>18 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsAntacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; reduces therapeutic effects of phenytoin; probenecid may increase serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT)
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsIn prolonged therapy, periodically evaluate organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy



Further Outpatient Care

  • Monitor patients to ensure complete resolution. Usually a follow-up visit one week after starting treatment is adequate.

Deterrence/Prevention

Some patients acquire otitis externa (OE) multiple times and should use a preventive strategy.

  • Earplugs worn for swimming and bathing are effective. Wipe earplugs with rubbing alcohol after use.
  • Acidifying drops placed in the ear after swimming or bathing also have a prophylactic benefit.

Complications

  • Complications of OE are rare. As mentioned, cellulitis or lymphadenitis may occur and should be treated with an oral antibiotic therapy.

Prognosis

  • Most incidents of OE resolve without difficulty.
  • Pain usually improves 2-5 days after initiating therapy.
  • Most incidents of OE resolve in 7-10 days.
  • In some patients with OE, the ear must be debrided prior to full resolution.

Patient Education



Medical/Legal Pitfalls

  • Failure to recognize necrotizing (ie, malignant) otitis externa (OE) is a significant pitfall. A patient who is diabetic or immunocompromised with severe pain in the ear should have necrotizing OE excluded by an otolaryngologist.
  • Although rare, malignant tumors of the ear canal sometimes are misdiagnosed as OE. If the condition does not respond to treatment as expected, an otolaryngologist should evaluate the patient.
  • Use of aminoglycoside antibiotic eardrops in the presence of a perforation or ventilation tube may cause problems. Although this is controversial, many otolaryngologists believe that aminoglycoside eardrops may be ototoxic if they enter the middle ear. In this situation, using an alternative such as quinolone drops may be safer.



Media file 1:  Acute otitis externa. The ear canal is red and edematous, and discharge is present.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  1. Rowlands S, Devalia H, Smith C, et al. Otitis externa in UK general practice: a survey using the UK General Practice Research Database. Br J Gen Pract. Jul 2001;51(468):533-8. [Medline].
  2. Roland PS. Chronic external otitis. Ear Nose Throat J. Jun 2001;80(6 Suppl):12-6. [Medline].
  3. Benjamin B, Bingham B, Hawke M. A Colour Atlas of Otorhinolaryngology. London, UK: Martin Dunitz Ltd; 1995.
  4. Bluestone CD, Klein JO. Otitis Media in Infants and Children. Philadelphia, PA: WB Saunders; 1988.
  5. Hawke M, Jahn AF. Diseases of the Ear: Clinical and Pathologic Aspects. Philadelphia, PA: JB Lippincott Co; 1988.
  6. Hawke M, Keene M, Alberti PW. Clinical Otoscopy: An Introduction to Ear Diseases. Edinburgh, UK: Churchill Livingstone; 1990.
  7. Holten KB, Gick J. Management of the patient with otitis externa. J Fam Pract. Apr 2001;50(4):353-60. [Medline].
  8. Hughes E, Lee JH. Otitis externa. Pediatr Rev. Jun 2001;22(6):191-7. [Medline].
  9. Tierney PA, Price T, Gillet D. Improving standards in the treatment of acute otitis externa by the use of a treatment protocol and open access to aural toilet. J Laryngol Otol. Feb 2001;115(2):87-90. [Medline].
  10. Waitzman AA, Hawke, M. Otoscopic examination: what to look for in the external ear. Consultant. 1996;36(5).
  11. Walshe P, Rowley H, Timon C. A worrying development in the microbiology of otitis externa. Clin Otolaryngol. Jun 2001;26(3):218-20. [Medline].

Otitis Externa excerpt

Article Last Updated: Mar 14, 2008